Page last updated: 2024-11-02

piperazine and Reperfusion Injury

piperazine has been researched along with Reperfusion Injury in 1 studies

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research Excerpts

ExcerptRelevanceReference
"Piperazine ferulate (PF) has been reported to protect cardiac from ischemia/reperfusion injury to achieve myocardial protection."8.12Piperazine ferulate protects against cardiac ischemia/reperfusion injury in rat via the suppression of NLRP3 inflammasome activation and pyroptosis. ( Lei, Z; Li, B; Liu, R; Liu, Y; Luan, F; Peng, L; Peng, X; Zeng, N; Zhang, X, 2022)
"Piperazine ferulate (PF) has been reported to protect cardiac from ischemia/reperfusion injury to achieve myocardial protection."4.12Piperazine ferulate protects against cardiac ischemia/reperfusion injury in rat via the suppression of NLRP3 inflammasome activation and pyroptosis. ( Lei, Z; Li, B; Liu, R; Liu, Y; Luan, F; Peng, L; Peng, X; Zeng, N; Zhang, X, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lei, Z1
Luan, F1
Zhang, X1
Peng, L1
Li, B1
Peng, X1
Liu, Y1
Liu, R1
Zeng, N1

Other Studies

1 other study available for piperazine and Reperfusion Injury

ArticleYear
Piperazine ferulate protects against cardiac ischemia/reperfusion injury in rat via the suppression of NLRP3 inflammasome activation and pyroptosis.
    European journal of pharmacology, 2022, Apr-05, Volume: 920

    Topics: Animals; Inflammasomes; Myocardial Infarction; Myocardial Reperfusion Injury; NLR Family, Pyrin Doma

2022